Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uterine endolymphatic stromal myosis: a collaborative study.

M S Piver, F N Rutledge, L Copeland

    Obstetrics and Gynecology
    |August 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Adapting evidence-informed population health interventions for new contexts: a scoping review of current practice.

    Health research policy and systems·2021
    Same author

    Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer.

    Gynecologic oncology·2020
    Same author

    Preserving US microbe collections sparks future discoveries.

    Journal of applied microbiology·2019
    Same author

    A comparison of anterior cruciate ligament - Return to sports after injury (ACL-RSI) scores of male athletes nine-months Post-ACL reconstruction with matched uninjured controls.

    Physical therapy in sport : official journal of the Association of Chartered Physiotherapists in Sports Medicine·2019
    Same author

    Technological advances in veterinary diagnostics: opportunities to deploy rapid decentralised tests to detect pathogens affecting livestock.

    Revue scientifique et technique (International Office of Epizootics)·2018
    Same author

    Assessment of scoring systems to describe the position of tracheostomy tubes within the airway - the lunar study.

    British journal of anaesthesia·2017
    Same journal

    The Political Determinants of Obstetric Prescribing.

    Obstetrics and gynecology·2026
    Same journal

    Glucagon-Like Peptide-1 Receptor Agonists and Risk of Adverse Maternal Pregnancy Outcomes: A Systematic Review and Meta-analysis.

    Obstetrics and gynecology·2026
    Same journal

    Milestones in Motion: Vaginal Birth After Cesarean.

    Obstetrics and gynecology·2026
    Same journal

    Ebola Virus in Pregnancy.

    Obstetrics and gynecology·2026
    Same journal

    A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

    Obstetrics and gynecology·2026
    Same journal

    The Effects of Climate Change on Obstetric and Gynecologic Health.

    Obstetrics and gynecology·2026
    See all related articles

    Uterine endolymphatic stromal myosis has a high recurrence rate after surgery. Long-term survival is achievable, partly due to hormonal sensitivity of recurrent tumors, necessitating a revised treatment plan.

    Area of Science:

    • Gynecologic Oncology
    • Surgical Pathology
    • Cancer Therapeutics

    Background:

    • Uterine endolymphatic stromal myosis (U-ESM) is a rare gynecologic malignancy.
    • High recurrence rates are observed following initial surgical management.
    • Understanding prognostic factors and treatment outcomes is crucial for patient care.

    Purpose of the Study:

    • To evaluate outcomes in patients with uterine endolymphatic stromal myosis.
    • To analyze recurrence patterns and survival rates based on surgical stage.
    • To propose an optimized therapeutic strategy for U-ESM.

    Main Methods:

    • Retrospective analysis of 52 cases of U-ESM.
    • Collaborative study by gynecologic oncologists.
    • Evaluation of initial surgical therapy, recurrence, and survival data.

    Related Experiment Videos

    Main Results:

    • Fifty percent of patients experienced disease recurrence post-surgery.
    • Stage I cases showed 47% pelvic and 9% distant recurrences.
    • Five- and ten-year survival rates varied by stage: Stage I (88%), Stage II (66%), Stage III (100%), Stage IV (75%).

    Conclusions:

    • Uterine endolymphatic stromal myosis has a significant recurrence rate.
    • Long-term survival is influenced by stage and hormonal sensitivity of tumors.
    • A revised therapeutic plan is recommended due to high recurrence rates.